PharmEasy IPO - Details

PharmEasy, a pharmacy startup run by API Holdings, is all set to make a public debut for its Initial Public Offering (IPO) to raise Rs. 6,250 Crores through the fresh issue. A Draft Red Herring Prospectus (DRHP) was filed by the company on November 10. The company is currently in discussions with bankers and may consider a private placement amounting to Rs. 1,250 crores. However, the implementation of private placement could narrow down the fresh issue.

Here is the break-up for the share allotment.

PharmEasy allotment

About PharmEasy

PharmEasy offers a dedicated healthcare platform offering a wide range of services, including diagnostic tests, online medicines and doctor consultations. Dharmil Sheth and Dr Dhaval Shah founded the company in 2015. The company acquired Medlife, Aknamed and Thyrocare earlier this year. Medlife is a publicly listed diagnostic chain, while Thyrocare and Aknamed are cloud-based hospital supply chain management startups.

Objectives of PharmEasy IPO

The objectives for PharmEasy IPO are stated below:

  1. The company intends to allocate Rs. 1,929 toward debt repayment and prepayment.
  2. PharmEasy will invest Rs. 1,259 Crores to fund organic growth.
  3. An amount worth Rs. 1,500 Crores would be dedicated to funding inorganic growth at the company through acquisitions and other strategic initiatives.
  4. General corporate purposes.

Why Should I Invest in PharmEasy IPO?

Here are a few driving factors for you to invest in PharmEasy shares.

  1. PharmEasy is India’s largest brand in healthcare services and pharma products. It offers a value proposition to all its stakeholders. The company currently serves 4,617 clinics and prescribing doctors, 87,194 pharmacies, 3,261 wholesalers and 926 hospitals. The company now has a count of 25 million registered users.
  2. Individuals who want to fulfil their prescription needs can benefit from PharmEasy teleconsultation services. API Holdings Limited uses this marketplace to offer facilities such as chronic disease management services and diagnostic tests.
  3. The company uses advanced technology, including MEAN stacks, LAMP and J2EE, and new-age programming constructs. Using data science models, PharmEasy has also developed various custom algorithms. Additionally, the firm uses specialised workflows and AI/ML techniques to support its business.
  4. PharmEasy maintains extensive and well-established healthcare-related data, which enables efficient strategic management and decision-making at the company. The company’s M&A team aims at exploiting opportunities in the fragmented healthcare market.
  5. The company provides a live and dynamic view of its logistics network and delivery timeframes for upcoming orders. Moreover, the company’s performance during the COVID-19 pandemic showed resilience to its business model. PharmEasy’s active customer base witnessed a spike to almost three million users within a few months.

How to Apply for PharmEasy IPO?

You can apply for PharmEasy IPO by placing bids from your Demat account. Alternatively, the UPI-based approach can also help you apply for the offering through the following steps.

  1. Your UPI ID must be linked to your bank account.
  2. Open a Demat account and link it with your UPI.
  3. Register for PharmEasy IPO and pay through your UPI ID.

Get Free* Demat Account


By continuing, I confirm that I have read and agree to the Terms & Conditions and Privacy Policy.

Frequently Asked Questions (FAQs)

PharmEasy is floating an IPO to raise Rs. 6,250 crores to manage existing debts and aid different corporate purposes.

The details are currently unavailable. However, PharmEasy unlisted share price is Rs. 115/share.

PharmEasy witnessed a growth of 220% in FY 2021. The company generated a revenue of Rs. 2,360 crores compared to Rs. 737.4 crores in 2020.

PharmEasy runs a healthcare e-commerce app offering an extensive range of facilities such as various diagnostic tests services, home delivery of consumer health products, teleconsultation services, OTC pharmaceuticals and much more.

Yes. PharmEasy is a startup company that offers a dedicated healthcare platform offering a wide range of services, including diagnostic tests, online medicines and doctor consultations.

Bajaj Broking
© Bajaj Financial Securities Ltd